Clinical Trial: A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-muscle-invasive Bladder Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer
Brief Summary:
This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.
Read more